These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34275470)

  • 1. Cost transferability problems in economic evaluation as a framework for an European health care and social costs database.
    García-Mochón L; Rovira Forns J; Espin J
    Cost Eff Resour Alloc; 2021 Jul; 19(1):43. PubMed ID: 34275470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the European Healthcare and Social Cost Database (EU HCSCD) for use in economic evaluation of healthcare programs.
    Espín J; Špacírová Z; Rovira J; Epstein D; Olry de Labry Lima A; García-Mochón L
    BMC Health Serv Res; 2022 Mar; 22(1):405. PubMed ID: 35346201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of day case costs and tariffs of cataract surgery from a sample of nine European countries.
    Olry de Labry Lima A; Špacírová Z; Espín J
    Cost Eff Resour Alloc; 2022 Mar; 20(1):11. PubMed ID: 35248070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another.
    Goeree R; Burke N; O'Reilly D; Manca A; Blackhouse G; Tarride JE
    Curr Med Res Opin; 2007 Apr; 23(4):671-82. PubMed ID: 17407623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme.
    Raftery J; Hanney S; Greenhalgh T; Glover M; Blatch-Jones A
    Health Technol Assess; 2016 Oct; 20(76):1-254. PubMed ID: 27767013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.
    Kristensen FB; Lampe K; Chase DL; Lee-Robin SH; Wild C; Moharra M; Garrido MV; Nielsen CP; Røttingen JA; Neikter SA; Bistrup ML;
    Int J Technol Assess Health Care; 2009 Dec; 25 Suppl 2():1-8. PubMed ID: 20030885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE.
    Mandrik O; Knies S; Kalo Z; Severens JL
    Int J Technol Assess Health Care; 2015; 31(6):434-41. PubMed ID: 26961722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges.
    Daubner-Bendes R; Kovács S; Niewada M; Huic M; Drummond M; Ciani O; Blankart CR; Mandrik O; Torbica A; Yfantopoulos J; Petrova G; Holownia-Voloskova M; Taylor RS; Al M; Piniazhko O; Lorenzovici L; Tarricone R; Zemplényi A; Kaló Z
    Front Public Health; 2020; 8():612410. PubMed ID: 33490024
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical Review of European Health-Economic Guidelines for the Health Technology Assessment of Medical Devices.
    Blüher M; Saunders SJ; Mittard V; Torrejon Torres R; Davis JA; Saunders R
    Front Med (Lausanne); 2019; 6():278. PubMed ID: 31850356
    [No Abstract]   [Full Text] [Related]  

  • 12. Economic Burden of Bladder Cancer Across the European Union.
    Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
    Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How can the impact of Health Technology Assessment (HTA) in the Austrian healthcare system be assessed? Design of a conceptual framework].
    Schumacher I; Zechmeister I
    Gesundheitswesen; 2012 Apr; 74(4):257-65. PubMed ID: 21267815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Criteria Decision Analysis for HTA across four EU Member States: Piloting the Advance Value Framework.
    Angelis A; Linch M; Montibeller G; Molina-Lopez T; Zawada A; Orzel K; Arickx F; Espin J; Kanavos P
    Soc Sci Med; 2020 Feb; 246():112595. PubMed ID: 31874372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.
    Berg ML; Cheung KL; Hiligsmann M; Evers S; de Kinderen RJA; Kulchaitanaroaj P; Pokhrel S
    Addiction; 2017 Jun; 112(6):946-967. PubMed ID: 28060453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation.
    Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S
    Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.